(53) performed 68Ga-PSMA-11 PET/CT imaging on 10 patients with metastatic CRC to assess metastasis avidity, and they showed that none of the patients exhibited tumor avidity sufficient to be considered for 177Lu-PSMA-617 PRRT. This evidence concerns the gene FOLH1 and neoplasm.